GPC2 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

204 results for “GPC2”

Trials

View all 68 →

Enrolling By Invitation

GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma

45 participants · First posted Dec 14, 2022

GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults

18 participants · First posted Jul 25, 2025

GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression

30 participants · First posted Jun 26, 2017

Drugs

View all 110 →

D3-GPC2-PBD

GPC2-CAR T cell (Stanford University)

anti-GPC2 ADC(The Children's Hospital of Philadelphia)

Organizations

GPCR Therapeutics, Inc.

South Korea

GPC Biotech AG

Germany

News

View all 24 →

First Preclinical mRNA Vaccine for Neuroblastoma Shrinks Tumors by 70% in Murine Models

Eureka's ARTEMIS CAR T Cells Demonstrate 16-Fold Superior Tumor Infiltration in Neuroblastoma Study

GPCR Dimers and Heteromers: Emerging Therapeutic Paradigms in Neuropsychiatric Disorders

Page 1 of 21